We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current 0KCS market cap is 2.88B. The company's latest EPS is USD -0.2443 and P/E is -6.18.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 916.79M | 1.44B | 1.78B | 1.01B | 864.53M |
| Operating Income | -207.88M | 57.71M | -12.76M | -244.81M | -157.02M |
| Net Income | -314.93M | 30.59M | -30.14M | -328.41M | -188.86M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.31B | 2.47B | 2.4B | 2.17B | 2.01B |
| Total Liabilities | 694.51M | 801.51M | 714.59M | 605.61M | 622.48M |
| Total Equity | 1.61B | 1.67B | 1.69B | 1.56B | 1.39B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -172.52M | 39.48M | 38.34M | -95.19M | -28.2M |
| Investing | -13.27M | -18.33M | 35.95M | 91.04M | -18.2M |
| Financing | 175.25M | -35.08M | -10.35M | 22.97M | -11.3M |
| Market Cap | 2.88B |
| Price to Earnings Ratio | -6.18 |
| Price to Sales Ratio | 1.35 |
| Price to Cash Ratio | 12.18 |
| Price to Book Ratio | 0.84 |
| Dividend Yield | - |
| Shares Outstanding | 773.06M |
| Average Volume (1 week) | 18.89k |
| Average Volume (1 Month) | 43.77k |
| 52 Week Change | 0.00% |
| 52 Week High | 3.72 |
| 52 Week Low | 3.72 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Opko Health Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.opko.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
